Pharmacokinetic variability with pembrolizumab dosage switching and its impact on immune-related adverse events in patients with non-small cell lung cancer
- DOI
- 10.1136/jitc-2026-015204
- Published
- 2026-06
- Container
- Journal for ImmunoTherapy of Cancer
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/jitc-2026-015204,
title = {Pharmacokinetic variability with pembrolizumab dosage switching and its impact on immune-related adverse events in patients with non-small cell lung cancer},
author = {Ryoko Inaba Higashiyama and Tatsuya Yoshida and Shigehiro Yagishita and Mayu Ohuchi and Yoshihiro Masui and Ken Masuda and Yuki Shinno and Yuji Matsumoto and Tomonori Mizutani and Yusuke Okuma and Yasushi Goto and Hidehito Horinouchi and Shohei Koyama and Noboru Yamamoto and Akinobu Hamada and Yuichiro Ohe},
year = {2026},
journal = {Journal for ImmunoTherapy of Cancer},
doi = {10.1136/jitc-2026-015204},
url = {https://doi.org/10.1136/jitc-2026-015204}
}RIS
TY - JOUR TI - Pharmacokinetic variability with pembrolizumab dosage switching and its impact on immune-related adverse events in patients with non-small cell lung cancer AU - Ryoko Inaba Higashiyama AU - Tatsuya Yoshida AU - Shigehiro Yagishita AU - Mayu Ohuchi AU - Yoshihiro Masui AU - Ken Masuda AU - Yuki Shinno AU - Yuji Matsumoto AU - Tomonori Mizutani AU - Yusuke Okuma AU - Yasushi Goto AU - Hidehito Horinouchi AU - Shohei Koyama AU - Noboru Yamamoto AU - Akinobu Hamada AU - Yuichiro Ohe PY - 2026 JO - Journal for ImmunoTherapy of Cancer DO - 10.1136/jitc-2026-015204 UR - https://doi.org/10.1136/jitc-2026-015204 ER -
APA
Higashiyama, R. I., Yoshida, T., Yagishita, S., Ohuchi, M., Masui, Y., Masuda, K., Shinno, Y., Matsumoto, Y., Mizutani, T., Okuma, Y., Goto, Y., Horinouchi, H., Koyama, S., Yamamoto, N., Hamada, A., & Ohe, Y. (2026). Pharmacokinetic variability with pembrolizumab dosage switching and its impact on immune-related adverse events in patients with non-small cell lung cancer. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2026-015204
Source records
- crossref · retrieved 2026-09-26T17:09:29.351Z